- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 6.20 Å
- Oligo State
- hetero-3-3-2-2-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.4: 3 residues within 4Å:- Chain B: G.16
- Chain D: E.57, N.58
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 3 residues within 4Å:- Chain D: R.162, I.164, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 7 residues within 4Å:- Chain D: Q.263, N.265, N.301, V.302, S.303, S.381, R.412
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 4 residues within 4Å:- Chain D: N.271, I.292, Q.408, G.409
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 7 residues within 4Å:- Chain D: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA.14, NAG-NAG-BMA.14
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 1 residues within 4Å:- Chain D: N.361
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 3 residues within 4Å:- Chain C: G.16
- Chain E: E.57, N.58
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 3 residues within 4Å:- Chain E: N.103, D.111, G.114
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 5 residues within 4Å:- Chain E: Q.100, S.120, F.121, N.122, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 3 residues within 4Å:- Chain E: R.162, I.164, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 7 residues within 4Å:- Chain E: Q.263, N.265, N.301, V.302, S.303, S.381, R.412
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 3 residues within 4Å:- Chain E: N.271, I.292, G.409
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 6 residues within 4Å:- Chain E: N.265, T.267, R.296, H.299, N.301, T.383
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:R.296
NAG-NAG.31: 3 residues within 4Å:- Chain A: G.16
- Chain F: E.57, N.58
No protein-ligand interaction detected (PLIP)NAG-NAG.34: 3 residues within 4Å:- Chain F: I.146, R.162, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.38: 7 residues within 4Å:- Chain F: Q.263, N.265, N.301, V.302, S.303, S.381, R.412
No protein-ligand interaction detected (PLIP)NAG-NAG.39: 4 residues within 4Å:- Chain F: N.271, I.292, Q.408, G.409
No protein-ligand interaction detected (PLIP)NAG-NAG.40: 5 residues within 4Å:- Chain F: N.265, T.267, H.299, N.301, T.383
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.7: 6 residues within 4Å:- Chain D: N.204
- Chain K: W.55, S.70, A.71, V.72, D.73
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:S.70, K:A.71, K:A.71, K:D.73
NAG-NAG-BMA-MAN.22: 6 residues within 4Å:- Chain E: N.204
- Chain O: W.55, S.70, A.71, V.72, D.73
1 PLIP interactions:1 interactions with chain O- Hydrogen bonds: O:S.70, O:A.71, O:A.71, O:D.73
NAG-NAG-BMA-MAN.35: 7 residues within 4Å:- Chain F: N.204, H.321
- Chain M: W.55, S.70, A.71, V.72, D.73
1 PLIP interactions:1 interactions with chain M- Hydrogen bonds: M:A.71
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.8: 8 residues within 4Å:- Chain D: K.35, N.232, N.346, G.348, I.407, C.413, V.414, S.415
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.23: 9 residues within 4Å:- Chain E: L.231, N.232, N.346, C.347, G.348, Q.408, C.413, V.414, S.415
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.36: 10 residues within 4Å:- Chain F: L.231, N.232, N.346, C.347, G.348, I.407, Q.408, C.413, V.414, S.415
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.9: 8 residues within 4Å:- Chain D: N.246, T.248, N.249
- Chain K: Q.1, H.3, Y.25, G.26, P.79
3 PLIP interactions:3 interactions with chain K- Hydrogen bonds: K:H.3, K:Q.1, K:Q.1, K:G.26
NAG-NAG-BMA-MAN.12: 6 residues within 4Å:- Chain D: N.265, T.267, R.296, H.299, N.301, T.383
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:R.296
- 7 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.14: 4 residues within 4Å:- Chain D: N.355, S.357
- Ligands: NAG-NAG.13, NAG-NAG.13
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.16: 4 residues within 4Å:- Chain D: P.261, V.262, Q.263, N.416
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 3 residues within 4Å:- Chain E: V.104, N.118, Y.135
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.28: 6 residues within 4Å:- Chain E: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG.53
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.41: 8 residues within 4Å:- Chain F: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA.42, NAG-NAG-BMA.42, NAG-NAG-BMA.42
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.42: 4 residues within 4Å:- Chain F: N.355, S.357
- Ligands: NAG-NAG-BMA.41, NAG-NAG-BMA.41
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.43: 4 residues within 4Å:- Chain F: P.261, V.262, Q.263, N.416
No protein-ligand interaction detected (PLIP)- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 13 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.45: 2 residues within 4Å:- Chain A: N.100, W.103
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:W.103
NAG.46: 2 residues within 4Å:- Chain B: N.100, W.103
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:W.103
NAG.47: 2 residues within 4Å:- Chain C: N.100, W.103
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:W.103
NAG.48: 1 residues within 4Å:- Chain D: N.103
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.103
NAG.49: 2 residues within 4Å:- Chain D: N.308, W.364
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:W.364
NAG.50: 1 residues within 4Å:- Chain D: N.324
No protein-ligand interaction detected (PLIP)NAG.51: 2 residues within 4Å:- Chain E: N.308, W.364
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.308
NAG.52: 1 residues within 4Å:- Chain E: N.324
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.324
NAG.53: 4 residues within 4Å:- Chain E: N.355, S.357
- Ligands: NAG-NAG-BMA.28, NAG-NAG-BMA.28
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:S.357
NAG.54: 6 residues within 4Å:- Chain F: N.103, D.111, G.114, K.117, R.140, K.159
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:K.117, F:R.140, F:R.140
NAG.55: 2 residues within 4Å:- Chain F: N.308, W.364
2 PLIP interactions:2 interactions with chain F- Hydrophobic interactions: F:W.364
- Hydrogen bonds: F:N.308
NAG.56: 1 residues within 4Å:- Chain F: N.324
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.324
NAG.57: 1 residues within 4Å:- Chain F: N.361
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.361
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, H. et al., Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies. Elife (2017)
- Release Date
- 2017-06-21
- Peptides
- Envelope glycoprotein gp160: ABC
Envelope glycoprotein gp160: DEF
BG1 Fab light chain: GI
BG1 Fab heavy chain: HJ
8ANC195 G52K5 Fab heavy chain: KMO
8ANC195 G52K5 Fab light chain: LNP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GI
IH
HJ
JK
KM
MO
OL
LN
NP
P
SMTL ID : 5viy.1
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195
Envelope glycoprotein gp160
Toggle Identical (ABC)Envelope glycoprotein gp160
Toggle Identical (DEF)BG1 Fab light chain
BG1 Fab heavy chain
Toggle Identical (HJ)8ANC195 G52K5 Fab heavy chain
Toggle Identical (KMO)8ANC195 G52K5 Fab light chain
Toggle Identical (LNP)Related Entries With Identical Sequence
4tvp.1 | 4zmj.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5i8h.1 | 5i8h.2 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5vj6.1 | 5vvf.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 more...less...6mu7.1 | 6mu8.1 | 6nf2.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6nqd.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mxe.1 | 7pc2.1 | 7rai.1 | 7sd3.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8czz.1 | 8dok.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g6u.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8jtd.1 | 8jtm.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8sw3.1 | 8sw4.1 | 8tjr.1 | 8tjs.1 | 8tkc.1 | 8tl2.1 | 8tl3.1 | 8tl4.1 | 8tl5.1 | 8tng.1 | 8tnh.1 | 8tni.1 | 8tnu.1 | 8to7.1 | 8top.1 | 8tq1.1 | 8ttw.1